Adjuvant properties of non-phospholipid liposomes (Novasomes®) in experimental animals for human vaccine antigens
- 1 February 1996
- Vol. 14 (3) , 219-225
- https://doi.org/10.1016/0264-410x(95)00182-z
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Method for quantitation of IgG subclass antibodies in mouse serum by enzyme-linked immunosorbent assayJournal of Immunological Methods, 1995
- Comparison of Adjuvant Activities of Aluminium Phosphate, Calcium Phosphate and Stearyl Tyrosine for Tetanus ToxoidBiologicals, 1994
- Liposomes as vaccine carriers: Incorporation of soluble and particulate antigens in giant vesiclesJournal of Immunological Methods, 1993
- Adjuvants — a balance between toxicity and adjuvanticityVaccine, 1993
- Liposomes as immunological adjuvants: approaches to immunopotentiation including ligand-mediated targeting to macrophagesResearch in Immunology, 1992
- Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.Journal of Clinical Investigation, 1992
- Liposome adjuvanticity: Influence of dose and protein: Lipid ratio on the humoral response to encapsulated and surface-linked antigenCellular Immunology, 1991
- Liposomes as carriers of antigens and adjuvantsJournal of Immunological Methods, 1991
- A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodiesJournal of Immunological Methods, 1981
- The Carrier Potential of Liposomes in Biology and MedicineNew England Journal of Medicine, 1976